These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35201850)

  • 21. Diffusion-weighted imaging in monitoring the pathological response to neoadjuvant chemotherapy in patients with breast cancer: a meta-analysis.
    Gao W; Guo N; Dong T
    World J Surg Oncol; 2018 Jul; 16(1):145. PubMed ID: 30021656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of Pathologic Complete Response in Breast Cancer Patients Comparing Magnetic Resonance Imaging with Ultrasound in Neoadjuvant Setting.
    Palshof FK; Lanng C; Kroman N; Benian C; Vejborg I; Bak A; Talman ML; Balslev E; Tvedskov TF
    Ann Surg Oncol; 2021 Nov; 28(12):7421-7429. PubMed ID: 34043094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of strain and shear-wave ultrasounic elastography in predicting the pathological response to neoadjuvant chemotherapy in breast cancers.
    Ma Y; Zhang S; Li J; Li J; Kang Y; Ren W
    Eur Radiol; 2017 Jun; 27(6):2282-2291. PubMed ID: 27752835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell-free circulating DNA integrity is an independent predictor of impending breast cancer recurrence.
    Cheng J; Cuk K; Heil J; Golatta M; Schott S; Sohn C; Schneeweiss A; Burwinkel B; Surowy H
    Oncotarget; 2017 Aug; 8(33):54537-54547. PubMed ID: 28903362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High Cell-Free DNA Integrity Is Associated with Poor Breast Cancer Survival.
    Lamminaho M; Kujala J; Peltonen H; Tengström M; Kosma VM; Mannermaa A
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of Magnetic Resonance Imaging in Detection of Pathologic Complete Remission in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: A Meta-analysis.
    Gu YL; Pan SM; Ren J; Yang ZX; Jiang GQ
    Clin Breast Cancer; 2017 Jul; 17(4):245-255. PubMed ID: 28209330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative intravoxel incoherent motion parameters derived from whole-tumor volume for assessing pathological complete response to neoadjuvant chemotherapy in locally advanced rectal cancer.
    Xu Q; Xu Y; Sun H; Chan Q; Shi K; Song A; Wang W
    J Magn Reson Imaging; 2018 Jul; 48(1):248-258. PubMed ID: 29281151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neoadjuvant breast cancer treatment response; tumor size evaluation through different conventional imaging modalities in the NeoDense study.
    Skarping I; Förnvik D; Heide-Jørgensen U; Rydén L; Zackrisson S; Borgquist S
    Acta Oncol; 2020 Dec; 59(12):1528-1537. PubMed ID: 33063567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Moderate physical activity during neoadjuvant chemotherapy in breast cancer patients: effect on cancer-related inflammation and pathological complete response-the Neo-Runner study.
    Garrone O; Paccagnella M; Abbona A; Ruatta F; Vanella P; Denaro N; Tomasello G; Croce N; Barbin F; Rossino MG; La Porta CAM; Sapino A; Torri V; Albini A; Merlano MC
    ESMO Open; 2024 Aug; 9(8):103665. PubMed ID: 39121813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. qRT-PCR-based DNA homologous recombination-associated 4-gene score predicts pathologic complete response to platinum-based neoadjuvant chemotherapy in triple-negative breast cancer.
    Zuo K; Yuan X; Liang X; Sun X; Liu S; Connell PP; Li X; Yang W
    Breast Cancer Res Treat; 2022 Jan; 191(2):335-344. PubMed ID: 34797456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neoadjuvant induction chemotherapy.
    Schwartz G
    Minerva Ginecol; 2005 Jun; 57(3):327-48. PubMed ID: 16166939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of mammograms using artificial intelligence to predict response to neoadjuvant chemotherapy in breast cancer patients: proof of concept.
    Skarping I; Larsson M; Förnvik D
    Eur Radiol; 2022 May; 32(5):3131-3141. PubMed ID: 34652522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of neoadjuvant chemotherapy regimen on relapse-free survival among patients with breast cancer achieving a pathologic complete response: an early step in the de-escalation of neoadjuvant chemotherapy.
    Weiss A; Bashour SI; Hess K; Thompson AM; Ibrahim NK
    Breast Cancer Res; 2018 Apr; 20(1):27. PubMed ID: 29661243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular types and neoadjuvant chemotherapy in patients with breast cancer- while molecular shifting is more common in luminal a tumors, the pathologic complete response is most frequently observed in her-2 like tumors.
    Salim DK; Mutlu H; Eryilmaz MK; Musri FY; Tural D; Gunduz S; Coskun HS
    Asian Pac J Cancer Prev; 2014; 15(21):9379-83. PubMed ID: 25422228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ICG fluorescence imaging as a new tool for optimization of pathological evaluation in breast cancer tumors after neoadjuvant chemotherapy.
    Veys I; Pop CF; Barbieux R; Moreau M; Noterman D; De Neubourg F; Nogaret JM; Liberale G; Larsimont D; Bourgeois P
    PLoS One; 2018; 13(5):e0197857. PubMed ID: 29799849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer. Translational Breast Cancer Research Consortium trial 017.
    De Los Santos JF; Cantor A; Amos KD; Forero A; Golshan M; Horton JK; Hudis CA; Hylton NM; McGuire K; Meric-Bernstam F; Meszoely IM; Nanda R; Hwang ES
    Cancer; 2013 May; 119(10):1776-83. PubMed ID: 23436342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diffusion-weighted magnetic resonance imaging for pretreatment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy.
    Nilsen L; Fangberget A; Geier O; Olsen DR; Seierstad T
    Acta Oncol; 2010 Apr; 49(3):354-60. PubMed ID: 20397769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting pathological axillary lymph node status with ultrasound following neoadjuvant therapy for breast cancer.
    Skarping I; Förnvik D; Zackrisson S; Borgquist S; Rydén L
    Breast Cancer Res Treat; 2021 Aug; 189(1):131-144. PubMed ID: 34120224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 18F-FDG PET/CT to Predict Response to Neoadjuvant Chemotherapy and Prognosis in Inflammatory Breast Cancer.
    Champion L; Lerebours F; Alberini JL; Fourme E; Gontier E; Bertrand F; Wartski M
    J Nucl Med; 2015 Sep; 56(9):1315-21. PubMed ID: 26159587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast Cancer: Influence of Taxanes on Response Assessment with Dynamic Contrast-enhanced MR Imaging.
    Schrading S; Kuhl CK
    Radiology; 2015 Dec; 277(3):687-96. PubMed ID: 26176656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.